Vimarsana
Biggest News Aggregation in the World

Pathalys Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pathalys Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pathalys Pharma Inc Today - Breaking & Trending Today

XORTX Welcomes New Member to the Board of Directors - Vimarsana News

XORTX Welcomes New Member to the Board of Directors

CALGARY, Alberta, Jan. 02, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors - Liquidia (NASDAQ:LQDA), Emergent BioSolutions (NYSE:EBS) - Vimarsana News

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors - Liquidia (NASDAQ:LQDA), Emergent BioSolutions (NYSE:EBS)

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors - Vimarsana News

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors

GAITHERSBURG, Md., Oct. 02, 2023 -- Emergent BioSolutions Inc. today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial...

Pathalys Pharma to Present at Jefferies Healthcare Conference - Vimarsana News

Pathalys Pharma to Present at Jefferies Healthcare Conference

/PRNewswire/ -- Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class...

Pathalys Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference - Vimarsana News

Pathalys Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference

/PRNewswire/ -- Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class...